Consensus statement on a framework for the management of comorbidity and extra-articular manifestations in rheumatoid arthritis-Reference-Cited by-同舟云学术

Consensus statement on a framework for the management of comorbidity and extra-articular manifestations in rheumatoid arthritis

Published:2014-12-28 Issue:3 Volume:35 Page:445-458
ISSN:0172-8172
Container-title:Rheumatology International
language:en
Short-container-title:Rheumatol Int

Author:

Loza Estíbaliz,Lajas Cristina,Andreu Jose Luis,Balsa Alejandro,González-Álvaro Isidoro,Illera Oscar,Jover Juan Ángel,Mateo Isabel,Orte Javier,Rivera Javier,Rodríguez Heredia José Manuel,Romero Fredeswinda,Martínez-López Juan Antonio,Ortiz Ana María,Toledano Esther,Villaverde Virginia,Carmona Loreto,Castañeda Santos

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s00296-014-3196-7.pdf

Reference94 articles.

1. van den Akker M, Buntinx F, Roos S, Knottnerus JA (2001) Problems in determining occurrence rates of multimorbidity. J Clin Epidemiol 54(7):675–679

2. Michaud K, Wolfe F (2007) Comorbidities in rheumatoid arthritis. Best Pract Res Clin Rheumatol 21(5):885–906

3. Gabriel SE, Michaud K (2009) Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther 11(3):229

4. Perez Edo L, Alonso Ruiz A, Roig Vilaseca D, Garcia Vadillo A, Guanabens Gay N, Peris P et al (2011) Up-date of the consensus statement of the Spanish Society of Rheumatology on osteoporosis. Reumatol Clin 7(6):357–379

5. Gomez Reino J, Loza E, Andreu JL, Balsa A, Batlle E, Canete JD et al (2011) Consensus statement of the Spanish Society of Rheumatology on risk management of biologic therapy in rheumatic patients. Reumatol Clin 7(5):284–298

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Funcionality assessed by the core set of the international classification of functionality and health for rheumatoid arthritis: A cohort study;PLOS ONE;2023-11-08

2. Reversing the Inflammatory Process—25 Years of Tumor Necrosis Factor-α Inhibitors;Journal of Clinical Medicine;2023-07-31

3. Current best clinical practices for monitoring of interstitial lung disease;Expert Review of Respiratory Medicine;2022-11-02

4. Openreuma Consensus on the role of nursing in the care of patients with rheumatoid arthritis and diffuse interstitial lung disease;INVESTIG EDUC ENFERM;2022

5. POS0612 COMORBIDITIES IN RHEUMATOID ARTHRITIS DO NOT INFLUENCE BIOLOGICS DRUG RETENTION: DATA FROM THE NATIONAL HEALTH INSURANCE FUND OF TUNIS;Annals of the Rheumatic Diseases;2022-05-23